Monte Rosa Therapeutics's total assets for Q1 2025 were $393.20M, a decrease of -10.38% from the previous quarter. GLUE total liabilities were $118.04M for the fiscal quarter, a -45.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.